Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Maini covers the Healthcare sector, focusing on stocks such as Sionna Therapeutics, Inc., Tenax Therapeutics, and Tectonic Therapeutic. According to TipRanks, Maini has an average return of 12.2% and a 75.00% success rate on recommended stocks.
In addition to LifeSci Capital, Sionna Therapeutics, Inc. also received a Buy from TD Cowen’s Ritu Baral in a report issued on May 13. However, on May 12, RBC Capital maintained a Sell rating on Sionna Therapeutics, Inc. (NASDAQ: SION).
Based on Sionna Therapeutics, Inc.’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $26.78 million. In comparison, last year the company had a GAAP net loss of $16.48 million
